A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell SubpopulationsSreenath V. Sharma, Jeff Settleman, Kwok‐Kin Wong et al.|Cell|2010Cited by 2.8k
The Cancer Stem Cell Marker Aldehyde Dehydrogenase Is Required to Maintain a Drug-Tolerant Tumor Cell SubpopulationDebasish Raha, Jeff Settleman|Cancer Research|2014Cited by 308
AXL Inhibition Sensitizes Mesenchymal Cancer Cells to Antimitotic DrugsCatherine Wilson, Jeff Settleman|Cancer Research|2014Cited by 145
Overcoming EMT-associated resistance to anti-cancer drugs via Src/FAK pathway inhibitionCatherine Wilson, Jeff Settleman|Oncotarget|2014Cited by 142
Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitorsGregory S. Ducker, Robert S. Warren, Chloé E. Atreya et al.|Oncogene|2013Cited by 92